REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avepharma, S. R. O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Periodical Publishers | Advertising Agencies
Full name: Avepharma, S. R. O. Profile Updated: July 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Avepharma, S. R. O. is a company in Slovakia, with a head office in Bratislava. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Avepharma, S. R. O. was incorporated on June 19, 2007. It currently has a total number of 5 - 9 (2025) employees. The company’s latest financial report indicates a net sales revenue increase of 2.98% in 2024. Its’ total assets recorded a growth of 41.79%. Avepharma, S. R. O.’s net profit margin increased by 1.85% in 2024.

Headquarters
Vajnorska, 100
Bratislava; Bratislavsky; Postal Code: 83104

Contact Details: Purchase the Avepharma, S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Avepharma, S. R. O. report to view the information.
Registered Capital:
Purchase the Avepharma, S. R. O. report to view the information.
Financial Auditors:
Purchase the Avepharma, S. R. O. report to view the information.
Incorporation Date:
June 19, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Avepharma, S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
2.98%▲
Total operating revenue
5.94%▲
Operating profit (EBIT)
40.08%▲
EBITDA
50.46%▲
Net Profit (Loss) for the Period
56.04%▲
Total assets
41.79%▲
Total equity
47.41%▲
Operating Profit Margin (ROS)
2.2%▲
Net Profit Margin
1.85%▲
Return on Equity (ROE)
1.78%▲
Debt to Equity Ratio
-62.25%▼
Quick Ratio
-0.69%▼
Cash Ratio
-0.95%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo